Epigenetic clocks: how old are you really?
Your ID states your age in years – your cells may see things differently. Epigenetic clocks try to measure your biological age. What holds up, and what doesn't.
Why two sixty-year-olds can be different ages
Chronological age counts years since birth. Biological age is meant to capture something different: the condition of cells and tissues. That the two can diverge is visible in everyday life — two people of the same birth year often differ considerably in physical resilience, recovery and disease risk.
Epigenetic clocks try to make this difference measurable. They do not read the genes themselves, but chemical tags attached to them: methyl groups that determine whether a gene is read or stays silent. This pattern changes with age in a remarkably consistent way.
How the clocks came about
Steve Horvath published the first widely applicable clock in 2013. He searched data from nearly eight thousand samples across fifty-one tissues for methylation sites linked to age, and found three hundred and fifty-three of them. From these he calculates an age that matches the actual age remarkably well.
Later clocks no longer target age but health. GrimAge by Lu and colleagues from 2019 was trained to predict lifespan and disease onset — and predicts mortality, heart disease and cancer risk considerably better than the first generation.
What a deviation means
What is interesting is not the calculated age itself, but its deviation from the chronological age — the so-called age acceleration. A positive value means: the methylation pattern looks older than the year of birth would suggest. In population studies this is associated with a higher risk of death.
The association applies to groups, however, not to individuals. For a single person the value varies considerably depending on the clock, laboratory and timing of the sample; the same blood sample can produce a difference of several years between two providers. As an individual statement, the result should therefore be read with great caution.
What the commercial tests are worth
For two hundred to five hundred francs, several providers offer a test from blood or saliva. What they deliver is a number with an uncertainty that is rarely disclosed. A repeat measurement a few weeks later often differs by two to five years — without anything having changed biologically.
No test of this kind is approved as a medical device, and no professional society recommends it for preventive care. It answers no question that would lead to treatment. Anyone who wants to spend money on diagnostics can get blood pressure, blood lipids, blood sugar, and inflammatory markers for a tenth of the price — values from which something can actually be derived.
What demonstrably influences the pattern
Some influences are well established: smoking accelerates the clocks significantly, as does severe obesity, chronic inflammation and persistent stress. Conversely, people with regular exercise, good sleep and stable social relationships show slower-running clocks in group analyses.
Whether the value can be deliberately reversed is an open question. A few small studies report a slowdown under certain programmes, but participant numbers are low and the results are not confirmed. Caution is especially warranted with providers who sell a test and the remedies to go with it.
How the YUTHI app helps you
If you have done one of these tests, you can enter the result with the date and provider and track it over time. This usually reveals something useful: how much the value fluctuates between two measurements — and therefore how much it is actually worth.
Vito and Vita put it in context rather than celebrating it. They show it alongside the values that are genuinely modifiable and treatable — blood pressure, blood sugar, blood lipids, inflammation, body composition — making it clear where the real leverage lies.
That was the snapshot. The app turns it into daily support.
Measure every day instead of calculating once: Vito or Vita puts your numbers in context, builds you a weekly plan and speaks up when something stands out.
Launching at the end of 2026 — iPhone first, Android to follow. Let me know when it’s out ↓
Sources
- Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115.
- Lu AT, Quach A, Wilson JG, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019;11(2):303-327.
- Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573-591.
- Bell CG, Lowe R, Adams PD, et al. DNA methylation aging clocks: challenges and recommendations. Genome Biol. 2019;20(1):249.